Department of Pathology, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan.
J Formos Med Assoc. 2010 Jun;109(6):463-71. doi: 10.1016/S0929-6646(10)60078-2.
BACKGROUND/PURPOSE: Gastric mucosa-associated lymphoid tissue lymphoma (MALToma) usually presents at an early stage involving only the stomach and/or regional lymph nodes. Although a sequential transformation from low-grade gastric MALToma (GM) to high-grade GM to secondary diffuse large B-cell lymphoma (DLBCL) is commonly assumed, documented cases of transformation are rare. We aim to determine the frequency of transformation.
We identified 55 early low-grade GMs, 18 early high-grade GMs, and 13 advanced GMs at the National Taiwan University Hospital from 1995 to 2005. The median follow-up time was 59 months.
We found that only one early low-grade GM and two early high-grade GMs transformed into secondary DLBCLs and progressed outside the stomach and regional lymph nodes. Significantly, we identified 13 low-grade GMs that were refractory to Helicobacter eradication therapy or relapsed after initial response. All 13 cases had been followed-up for at least 3 years without development of secondary DLBCLs. The frequency of transformation for early low-grade GM was less than 2% (1/55). Although two lymphoma-unrelated mortalities were identified, none of the 55 patients with early-low grade GMs died of the disease.
Compared with chronic lymphocytic leukemia, which has a 16% transformation rate and a median transformation time of 24 months, we conclude that early low-grade GM rarely transforms into secondary DLBCL or progresses beyond the stomach. Without transformation or progression, patients with early low-grade GM rarely die of the disease and should be treated conservatively.
背景/目的:胃黏膜相关淋巴组织淋巴瘤(MALToma)通常在早期出现,仅累及胃和/或局部淋巴结。尽管通常假定从低级别胃 MALToma(GM)到高级别 GM 再到继发性弥漫性大 B 细胞淋巴瘤(DLBCL)的连续转化,但有文献记载的转化病例很少。我们旨在确定转化的频率。
我们从 1995 年至 2005 年在国立台湾大学医院确定了 55 例早期低级别 GM、18 例早期高级别 GM 和 13 例晚期 GM。中位随访时间为 59 个月。
我们发现只有 1 例早期低级别 GM 和 2 例早期高级别 GM 转化为继发性 DLBCL,并在胃和局部淋巴结外进展。值得注意的是,我们确定了 13 例对幽门螺杆菌根除治疗无反应或初始反应后复发的低级别 GM。这 13 例均至少随访 3 年,未发生继发性 DLBCL。早期低级别 GM 的转化频率小于 2%(1/55)。虽然发现了 2 例与淋巴瘤无关的死亡,但55 例早期低级别 GM 患者均未因疾病死亡。
与转化率为 16%且中位转化时间为 24 个月的慢性淋巴细胞白血病相比,我们得出的结论是早期低级别 GM 很少转化为继发性 DLBCL 或超出胃的范围进展。没有转化或进展,早期低级别 GM 患者很少因疾病死亡,应保守治疗。